This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. shed 3.6% to $9.78 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 19,714.27 and the Dow Jones Industrial Average rising 0.4% to 44,470.41.
This was the stock's third consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 84.2% below its 52-week high of $61.90, which the company achieved on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors, as Vanda Pharmaceuticals Inc. fell 3.8% to $4.62, Fortress Biotech Inc. fell 2.0% to $1.75, and Viking Therapeutics Inc. fell 7.34% to $30.17.
Trading volume totaled 320,871, compared to the 50-day average of 258,027.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 10, 2025 16:45 ET (21:45 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。